Market Tracker

07/31 6:01pm ET

Emergent BioSolutions Inc (NYSE:EBS)

32.83
Delayed Data
As of Jul 31
 +0.07 / +0.21%
Today’s Change
19.31
Today|||52-Week Range
34.50
+20.57%
Year-to-Date

Today’s Trading

Previous close32.76
Today’s open32.82
Day’s range32.27 - 33.40
Volume157,054
Average volume (3 months)251,370
Market cap$1.3B
Dividend yield--
Data as of 4:04pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+3.53%
Earnings growth (this year)+39.45%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+8.49%
P/E ratio42.7
Price/Sales3.68
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.44+1.18%
CLLSCellectis SA+1.27+3.68%
SRPTSarepta Therapeutics...+0.16+0.50%
RGENRepligen Corp+0.03+0.09%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.11
Annual revenue (last year)$339.3M
Annual profit (last year)$36.7M
Net profit margin10.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Rockville, Maryland

Forecasts